Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · IEX Real-Time Price · USD
29.32
+0.39 (1.35%)
Apr 26, 2024, 4:00 PM EDT - Market closed
HRMY Employees
Harmony Biosciences Holdings had 246 employees on December 31, 2023. The number of employees increased by 46 or 23.00% compared to the previous year.
Employees
246
Change (1Y)
46
Growth (1Y)
23.00%
Revenue / Employee
$2,365,943
Profits / Employee
$523,793
Market Cap
1.66B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 246 | 46 | 23.00% |
Dec 31, 2022 | 200 | 20 | 11.11% |
Dec 31, 2021 | 180 | 30 | 20.00% |
Dec 31, 2020 | 150 | 0 | - |
Dec 31, 2019 | 150 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UFP Technologies | 3,093 |
Myriad Genetics | 2,700 |
Schrödinger | 867 |
Alphatec Holdings | 839 |
Supernus Pharmaceuticals | 652 |
Beam Therapeutics | 507 |
Agios Pharmaceuticals | 386 |
Inhibrx | 172 |
HRMY News
- 12 days ago - HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024 - PRNewsWire
- 17 days ago - HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST - PRNewsWire
- 25 days ago - HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME - PRNewsWire
- 4 weeks ago - HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE - PRNewsWire
- 2 months ago - HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES - PRNewsWire
- 2 months ago - Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates - GlobeNewsWire
- 2 months ago - U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX® (PITOLISANT) IN PEDIATRIC NARCOLEPSY - PRNewsWire
- 2 months ago - HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT IN PRADER-WILLI SYNDROME - PRNewsWire